Evidence map›Paper›PMID 40137915›Full record

ArticleToxins2025

Selective Modulation of Osteoclast Function by

Fernanda D'Amélio, Hugo Vigerelli, Isabel de Fátima Correia Batista, Rodrigo Pinheiro Araldi, Álvaro R B Prieto-da-Silva, Daniel Carvalho Pimenta, Irina Kerkis

Abstract read
In one paragraph

Article in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Transcriptomic Dissection ofInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fernanda D'AmélioLaboratory of Genetics, Butantan Institute, São Paulo 05503-900, Brazil.
Hugo VigerelliCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0002-8197-2260
Isabel de Fátima Correia BatistaCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0001-7398-4184
Rodrigo Pinheiro AraldiLaboratory of Genetics, Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0001-8288-2577
Álvaro R B Prieto-da-SilvaLaboratory of Genetics, Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0003-0289-9809
Daniel Carvalho PimentaLaboratory of Biochemistry and Biophysics, Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0003-2406-0860
Irina KerkisLaboratory of Genetics, Butantan Institute, São Paulo 05503-900, Brazil.

Funding

GSK 2015/50040-4
6 · The paper itself

Abstract

Our study explores the differential effects of

Indexed as

Bone DiseasesBothropsCrotalid VenomsOsteoclastsAnimalsCytokinesMiceOsteogenesisVenomous SnakesCrotalid VenomsCytokinesBothrops moojenifunctionhigh- and low-molecular-weight fractionmolecular targetsmorphologyosteoclastsecretome

Identifiers

PMID40137915
PMCPMC11946621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.